AG Kaderali Bioinformatics / Mathematical Modeling of Infection
|
|
- Evangeline Day
- 6 years ago
- Views:
Transcription
1 AG Kaderali Bioinformatics / Mathematical Modeling of Infection Prof. Dr. Lars Kaderali Hiddensee, October 27, 2015 Institut für Bioinformatik
2 Research Overview Experimental Data High-Throughput Screening 1 Gene Expression Microarrays Live Cell Imaging... Next Generation Sequencing Statistical and Bioinformatics Methods for (raw) Data Processing Forward Modeling 2 Mathematical Modeling 3 Network Bioinformatics -quantitative, dynamic understanding of infection processes - Projects on Viral Replication, Immune Response, Interaction between virus and immune system, drug effects -learn predictive models from data -data mining - several projects on understanding host-pathogen interactions e.g. from RNAi screening or sequencing data Inverse Modeling Integrate these approaches to understand Infection and Immune Response
3 SysVirDrug: Novel Antiviral Drugs! Most antiviral drugs inhibit viral enzymes - Spectrum of activity? (may not target all types) - Development of resistance - Less chance of side-effects Growing interest in developing inhibitors of essential host factors - Broad spectrum (related viruses use common replication strategy) - - Host factors unlikely to become resistant viral RNA - Side-effects?
4 RNAi to Identify Host-Pathogen Interactions Virus nuclei neg. control Host Factor Hepatitis C virus Dengue virus High-throughput, SARS-coronavirus sirna-based Screening Chikungunya virus Enterovirus (Coxsackie B3) Sophisticated, networkand pathway-based Bioinformatics Analysis Reiss, Woerz et al., Cell Host&Microbe 2011 Pönisch et al., PLoS Pathogens, 2015 Amberkar&Kaderali, BMC Alg Mol Biol, 2015
5 Model Analysis and Inhibitor Design Model Analysis Virtual screening Host Factors Experimental Validation Mathematical Model Antiviral Compounds
6 Mathematical Model to Explain Differences in Cellular Hep-C Virus Replication Permissivenes Difference in replication in high and low permissive cells is explained by the different expression level of a host factor which participates in the formation of replication vesicles Binder et al., PLoS Pathogens, 2009 Clausznitzer et al., Virus Res., 2015 Ivanisenko et al., PLOS One, 2014
7 Sensitivity Analysis Interference with RNA polymerization is significantly more potent than impeding protease activity!
8 Modeling Innate Immune Recognition m r + i m m i k M k -M (i, L) k F m i m i Cooperativity of the Rig-I RNA binding reaction underlies nonlinear features of pathway activation F 1600 bp 400 bp 200 bp 100 bp 40 bp Binder et al., J Biol Chem, 2011 ImmunoQuant
9 Outlook: Systems Biology of Infection Host Factors PK / PD Models Innate & Adaptive Immune Response Cell Populations, Tissues, Organs,... Transfected RNA Viral Life Cycle Model Ribosomes RNA processed Polyprotein Translation complexes RIG-I Pathway Cellular factor Viral polymerase, NS5B New plusstrand RNA + Plus-strand intermediate complex Polymerase Clinical Data Minus-strand intermediate complex Polymerase Minus-strand RNA Influence of additional host factors Comparison accross different viruses Optimization of Intervention Strategies (Drug Combinations) PK/PD models + Polymerase Jak/Stat Pathway
10 Possible Collaborations What we can offer High-throughput data analysis (biostatistics, bioinformatics) Data integration, data mining on infection processes Mathematical modeling of infection and immune response Computer simulations of infectious processes, mathematical modeling and model analysis to generate / test hypotheses about mechanisms What we are looking for New collaborations in particular with experimental / virological / immunological partners on elucidating host-pathogen interactions High-Throughput ( global view ) data for bioinformatics analysis Detailed dynamic data for development of kinetic mathematical models So far worked with viruses, many of the methods and tools used should be transferable to bacteria
VIRUSES. 1. Describe the structure of a virus by completing the following chart.
AP BIOLOGY MOLECULAR GENETICS ACTIVITY #3 NAME DATE HOUR VIRUSES 1. Describe the structure of a virus by completing the following chart. Viral Part Description of Part 2. Some viruses have an envelope
More informationAREAS OF CONCENTRATION
Dr. Shruti Mehta, Director The development of antibiotics, improved access to safe food, clean water, sewage disposal and vaccines has led to dramatic progress in controlling infectious diseases. Despite
More informationHepatitis B Antiviral Drug Development Multi-Marker Screening Assay
Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay Background ImQuest BioSciences has developed and qualified a single-plate method to expedite the screening of antiviral agents against
More informationCoronaviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics
Coronaviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Virion Spherical enveloped particles studded with clubbed spikes Diameter 120-160 nm Coiled helical
More informationIntrinsic cellular defenses against virus infection
Intrinsic cellular defenses against virus infection Detection of virus infection Host cell response to virus infection Interferons: structure and synthesis Induction of antiviral activity Viral defenses
More informationVIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON
VIRUSES Biology Applications Control David R. Harper GS Garland Science Taylor & Francis Group NEW YORK AND LONDON vii Chapter 1 Virus Structure and 2.2 VIRUS MORPHOLOGY 26 Infection 1 2.3 VIRAL CLASSIFICATION
More informationPicornaviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics
Picornaviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Virion Naked icosahedral capsid (T=1) Diameter of 30 nm Genome Linear single-stranded RNA, positive
More informationthe world and viruses
More than 5,450 viruses belonging to more than 2,000 species, 287 genera, 73 families and 3 orders are recognized in the 8th ICTVreport report. the world and viruses 1 1889 H2N2 Emerging viruses in the
More informationEnvelope e_ :------, Envelope glycoproteins e_ ~ Single-stranded RNA ----, Nucleocapsid
Virus Antib(tdies Your Expertise, Our Antibodies, Accelerated Discovery. Envelope e_---------:------, Envelope glycoproteins e_-------1~ Single-stranded RNA ----, Nucleocapsid First identified in 1989,
More informationVirus Genetic Diversity
Virus Genetic Diversity Jin-Ching Lee, Ph.D. 李 jclee@kmu.edu.tw http://jclee.dlearn.kmu.edu.t jclee.dlearn.kmu.edu.tw TEL: 2369 Office: N1024 Faculty of Biotechnology Kaohsiung Medical University Outline
More informationDiagnosis of infectious diseases and confirmation of diagnosis. Molecular epidemiology of emerging/re-emerging pathogens
LA PREPARAZIONE E LA RISPOSTA ALLE EMERGENZE INFETTIVE Padova, 20 settembre 2012 Laboratory advanced technologies in the support of Public Health interventions in infectious disease emergencies Prof. Giorgio
More information- STATEMENT OF WORK - Task Authorization (TA) - 38
1. NUMBER TITLE OF TASK AUTHORIZATION TA Broad spectrum antivirals against RNA viruses which block cellular entry. 2. VALIDATION OF SCOPE OF CONTRACT The following task(s), as written in the SOW of the
More informationForward Looking Statements
Slide title Forward Looking Statements This presentation may contain forward looking statements with respect to the financial condition, results and business achievements/performance of Biotron Limited
More informationDiscovery of Potent, Highly Selective, Broad Spectrum Antivirals
Discovery of Potent, Highly Selective, Broad Spectrum Antivirals Fred Hutch/Merck Infectious Disease Summit May 10, 2018 Sam Lee, Ph.D. 1 Forward Looking Statements This presentation contains forward-looking
More informationOctober 26, Lecture Readings. Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell
October 26, 2006 Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell 1. Secretory pathway a. Formation of coated vesicles b. SNAREs and vesicle targeting 2. Membrane fusion a. SNAREs
More information1. Virus 2. Capsid 3. Envelope
VIRUSES BIOLOGY II VOCABULARY- VIRUSES (22 Words) 1. Virus 2. Capsid 3. Envelope 4. Provirus 5. Retrovirus 6. Reverse transcriptase 7. Bacteriophage 8. Lytic Cycle 9. Virulent 10. Lysis 11. Lysogenic Cycle
More informationAP Biology. Viral diseases Polio. Chapter 18. Smallpox. Influenza: 1918 epidemic. Emerging viruses. A sense of size
Hepatitis Viral diseases Polio Chapter 18. Measles Viral Genetics Influenza: 1918 epidemic 30-40 million deaths world-wide Chicken pox Smallpox Eradicated in 1976 vaccinations ceased in 1980 at risk population?
More informationImage of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS
Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS APRIL 2017 Infectious viruses are a global health threat Since the approval of the first antiviral drug
More informationVirus-host interactions
Virus-host interactions - Strategies viruses use to replicate their genomes in susceptible host cells replication - Strategies viruses use to move their genomes throughout susceptible host plants cell-to-cell
More informationImage of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS
Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS MAY 2017 1 Infectious viral pathogens are a significant global health threat to mankind 2 Since the approval
More informationnumber Done by Corrected by Doctor Ashraf
number 4 Done by Nedaa Bani Ata Corrected by Rama Nada Doctor Ashraf Genome replication and gene expression Remember the steps of viral replication from the last lecture: Attachment, Adsorption, Penetration,
More informationChapter 13B: Animal Viruses
Chapter 13B: Animal Viruses 1. Overview of Animal Viruses 2. DNA Viruses 3. RNA Viruses 4. Prions 1. Overview of Animal Viruses Life Cycle of Animal Viruses The basic life cycle stages of animal viruses
More informationReverse Genetics of RNA Viruses
Reverse Genetics of RNA Viruses Reverse Genetics (RG) he creation of a virus with a fulllength copy of the viral genome he most powerful tool in modern virology RG of RNA viruses Generation or recovery
More informationLecture 2 Evolution in action: the HIV virus
Lecture 2 Evolution in action: the HIV virus Peter and Rosemary Grant Barry Sinervo The HIV/AIDS pandemic Life expectancy in Botswana What is HIV? What is HIV? HIV is a retrovirus (i.e., RNA-based) with
More information18.2 Viruses and Prions
KEY CONCEPT Infections can be caused in several ways. Viruses, bacteria, viroids, and prions can all cause infection. Any disease-causing agent is called a pathogen. 1 nanometer (nm) = one billionth of
More informationHepatitis B. HBV Cure: Insights for the Biotechnology and the Research Analyst Community November 11, Lalo Flores, PhD Global Head HBV R&D
Hepatitis B HBV Cure: Insights for the Biotechnology and the Research Analyst Community November 11, 2016 Lalo Flores, PhD Global Head HBV R&D Infectious Diseases Diseases Infectious 11 Janssen s Vision
More informationAP Biology Reading Guide. Concept 19.1 A virus consists of a nucleic acid surrounded by a protein coat
AP Biology Reading Guide Name Chapter 19: Viruses Overview Experimental work with viruses has provided important evidence that genes are made of nucleic acids. Viruses were also important in working out
More informationLecture 2: Virology. I. Background
Lecture 2: Virology I. Background A. Properties 1. Simple biological systems a. Aggregates of nucleic acids and protein 2. Non-living a. Cannot reproduce or carry out metabolic activities outside of a
More informationViral reproductive cycle
Lecture 29: Viruses Lecture outline 11/11/05 Types of viruses Bacteriophage Lytic and lysogenic life cycles viruses viruses Influenza Prions Mad cow disease 0.5 µm Figure 18.4 Viral structure of capsid
More informationInarigivir ACHIEVE Trial Results and HBV Clinical Program Update. August 2, 2018
Inarigivir ACHIEVE Trial Results and HBV Clinical Program Update August 2, 2018 FORWARD LOOKING STATEMENT This presentation includes forward-looking statements within the meaning of the Private Securities
More informationAre Immune Modulators Really Needed to Cure HBV infection?
Are Immune Modulators Really Needed to Cure HBV infection? Harry L.A. Janssen Francis Family Chair of Hepatology Director Toronto Centre for Liver Disease University Health Network University of Toronto,
More informationBioinformation by Biomedical Informatics Publishing Group
Predicted RNA secondary structures for the conserved regions in dengue virus Pallavi Somvanshi*, Prahlad Kishore Seth Bioinformatics Centre, Biotech Park, Sector G, Jankipuram, Lucknow 226021, Uttar Pradesh,
More informationChapter13 Characterizing and Classifying Viruses, Viroids, and Prions
Chapter13 Characterizing and Classifying Viruses, Viroids, and Prions 11/20/2017 MDufilho 1 Characteristics of Viruses Viruses Minuscule, acellular, infectious agent having either DNA or RNA Cause infections
More informationSection Lectures: Immunology/Virology Time: 9:00 am 10:00 am LRC 105 A & B
Section Director: Cliff Bellone, Ph.D. Office: Doisy Hall - R 405 Phone: 577-8449 E-Mail: bellonec@slu.edu Lecturers: James Swierkosz, Ph.D. Office: Medical School Rm. 412 Phone: 577-8430 E-Mail: swierkoszje@slu.edu
More informationCover Page. The following handle holds various files of this Leiden University dissertation:
Cover Page The following handle holds various files of this Leiden University dissertation: http://hdl.handle.net/188/59466 Author: Oudshoorn, D. Title: Wrapping up : nidovirus membrane structures and
More informationVirusDetect pipeline - virus detection with small RNA sequencing
VirusDetect pipeline - virus detection with small RNA sequencing CSC webinar 16.1.2018 Eija Korpelainen, Kimmo Mattila, Maria Lehtivaara Big thanks to Jan Kreuze and Jari Valkonen! Outline Small interfering
More informationLESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV
LESSON 4.6 WORKBOOK Designing an antiviral drug The challenge of HIV In the last two lessons we discussed the how the viral life cycle causes host cell damage. But is there anything we can do to prevent
More informationLESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication
DEFINITIONS OF TERMS Eukaryotic: Non-bacterial cell type (bacteria are prokaryotes).. LESSON 4.4 WORKBOOK How viruses make us sick: Viral Replication This lesson extends the principles we learned in Unit
More informationLaub Developing Humates with Anti-HIV, HSV, HPV and Other Antiviral Activity Laub Biochemicals Corp. (Newport Beach, CA) is developing purely syntheti
Laub Developing Humates with Anti-HIV, HSV, HPV and Other Antiviral Activity Laub Biochemicals Corp. (Newport Beach, CA) is developing purely synthetic non-toxic humates (humic acid derivatives), trade-marked
More informationBiol115 The Thread of Life"
Biol115 The Thread of Life" Lecture 9" Gene expression and the Central Dogma"... once (sequential) information has passed into protein it cannot get out again. " ~Francis Crick, 1958! Principles of Biology
More informationForward Looking Statements
Antiviral Therapies Forward Looking Statements This presentation contains forward-looking statements, including the timing of our drug development programs. Risks include delays in manufacturing created
More informationLahore University of Management Sciences. BIO314 Virology and Microbiology (Spring 2015)
BIO314 Virology and Microbiology (Spring 2015) Instructor Room. Office Hours Email Telephone Secretary/TA TA Office Hours Course URL (if any) Shaper Mirza and Sadia Hamera Shaper.Mirza@uth.tmc.edu Course
More informationINTERfering and Co-Evolving Prevention and Therapy (INTERCEPT) Proposers Day
INTERfering and Co-Evolving Prevention and Therapy (INTERCEPT) Proposers Day Dr. Jim Gimlett, Program Manager DARPA Biological Technologies Office (BTO) April 28, 2016 Arlington, VA INTERCEPT Agenda INTERCEPT
More informationRNAi in HBV, the next backbone therapy for use in combinations? Bruce D. Given, MD COO, Arrowhead Pharmaceuticals L.I.F.E.R.
RNAi in HBV, the next backbone therapy for use in combinations? Bruce D. Given, MD COO, Arrowhead Pharmaceuticals L.I.F.E.R. October 20, 2017 Safe Harbor Statement This presentation contains forward-looking
More informationB. Incorrect! Peginterferon α-2a is used for the treatment of chronic hepatitis B and may be preferable to interferon- α.
Pharmacology - Problem Drill 24: Antibiotics, Antifungal and Antiviral Drugs Question No. 1 of 10 1. reduces the replication of influenza A and B viruses by inhibiting viral neuraminidase. Question #01
More informationOverview: Chapter 19 Viruses: A Borrowed Life
Overview: Chapter 19 Viruses: A Borrowed Life Viruses called bacteriophages can infect and set in motion a genetic takeover of bacteria, such as Escherichia coli Viruses lead a kind of borrowed life between
More informationMedical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University
Medical Virology Immunology Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University Human blood cells Phases of immune responses Microbe Naïve
More informationAntibacterials and Antivirals
Structure of a Bacterium: Antibacterials and Antivirals Capsule: protective layer made up of proteins, sugars and lipids Cell wall: provides the bacteria with its shape and structure Cell membrane: permeable
More informationSYSTEMS BIOLOGY APPROACHES TO IDENTIFY MECHANISMS OF IMMUNE MEDIATED PROTECTION TRANSLATING RESEARCH INTO HEALTH
SYSTEMS BIOLOGY APPROACHES TO IDENTIFY MECHANISMS OF IMMUNE MEDIATED PROTECTION TRANSLATING RESEARCH INTO HEALTH Novel assays to decipher protective immune responses Decoding the immune response to infectious
More informationLahore University of Management Sciences. BIO 314- Microbiology and Virology (Spring 2018)
BIO 314- Microbiology and Virology (Spring 2018) Instructor Shaper Mirza Room No. 9-318A Office Hours TBA Email Shaper.Mirza@uth.tmc.edu ; shaper.mirza@lums.edu.pk Telephone 8413 Secretary/TA No TA Office
More informationPart I. Content: History of Viruses. General properties of viruses. Viral structure. Viral classifications. Virus-like agents.
Viruses Part I Content: History of Viruses. General properties of viruses. Viral structure. Viral classifications. Virus-like agents. History Through the 1800s, many scientists discovered that something
More informationNS1 Protein Expression in the JaOArS982 Strain of Japanese Encephalitis Virus Does Not Enhance Virulence in Mice
Tropical Medicine and Health Vol. 43 No.4, 2015, 233 237 doi: 10.2149/tmh.2015-27 Copyright 2015 by The Japanese Society of Tropical Medicine 233 Short Communications NS1 Protein Expression in the JaOArS982
More informationBi 8 Lecture 17. interference. Ellen Rothenberg 1 March 2016
Bi 8 Lecture 17 REGulation by RNA interference Ellen Rothenberg 1 March 2016 Protein is not the only regulatory molecule affecting gene expression: RNA itself can be negative regulator RNA does not need
More informationALN-HBV. Laura Sepp-Lorenzino November 11, Alnylam Pharmaceuticals, Inc.
ALN-HBV Laura Sepp-Lorenzino November 11, 2016 2016 Alnylam Pharmaceuticals, Inc. 1 N-Acetyl Galactosamine (GalNAc) sirna Conjugates Subcutaneous Investigational RNAi Therapeutics 5 -sense 5 -AS ASGPR
More informationStructure of viruses
Antiviral Drugs o Viruses are obligate intracellular parasites. o lack both a cell wall and a cell membrane. o They do not carry out metabolic processes. o Viruses use much of the host s metabolic machinery.
More informationHEPATITIS C VIRUS: NEW DIAGNOSTIC TOOLS By (hepatitis)
HEPATITIS C VIRUS: NEW DIAGNOSTIC TOOLS By (hepatitis) If looking for the book by (hepatitis) HEPATITIS C VIRUS: NEW DIAGNOSTIC TOOLS in pdf form, then you've come to the right website. We present full
More informationCHAPTER ONE: EXECUTIVE SUMMARY
CHAPTER ONE: EXECUTIVE SUMMARY Introduction Scope and Methodology Total Size and Growth of the Market Issues and Trends Affecting Market Leading Competitors CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS
More informationPhenomena first observed in petunia
Vectors for RNAi Phenomena first observed in petunia Attempted to overexpress chalone synthase (anthrocyanin pigment gene) in petunia. (trying to darken flower color) Caused the loss of pigment. Bill Douherty
More informationProtein Structure and Computational Biology, Good morning and welcome!
Protein Structure and Computational Biology, 27617 Good morning and welcome! Program 9.00-9.30 Introduction to the course 9.30-9.40 Break 9.40-10.00 Introduction to influenza a recurring case story 10.00-10.10
More informationMicrobiological Societies (IUMS) Congress This conference took place in Montreal, CANADA during
(Abroad Domestic)Official trip report form(student) 2014/08/19 (Year/Month/Day) Name Laboratory Year (Grade) Destination Nipawit Karnbunchob Division of Bioinformatics DC2 Montreal, CANADA Period of trip
More information2017 UnitedHealthcare Services, Inc.
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1146-7 Program Prior Authorization/Notification Medication Harvoni (ledipasvir/sofosbuvir) P&T Approval Date 10/2014, 2/2015,
More informationReplication Defective Enterovirus Infections: Implications for Type I Diabetes
Replication Defective Enterovirus Infections: Implications for Type I Diabetes N. M. Chapman Department of Pathology & Microbiology University of Nebraska Medical Center Enterovirus Genome and 2 Capsid
More information5/6/17. Diseases. Disease. Pathogens. Domain Bacteria Characteristics. Bacteria Viruses (including HIV) Pathogens are disease-causing organisms
5/6/17 Disease Diseases I. II. Bacteria Viruses (including HIV) Biol 105 Chapter 13a Pathogens Pathogens are disease-causing organisms Domain Bacteria Characteristics 1. Domain Bacteria are prokaryotic.
More informationPolyomaviridae. Spring
Polyomaviridae Spring 2002 331 Antibody Prevalence for BK & JC Viruses Spring 2002 332 Polyoma Viruses General characteristics Papovaviridae: PA - papilloma; PO - polyoma; VA - vacuolating agent a. 45nm
More informationStructure & Function of Viruses
Structure & Function of Viruses Discovery of Viruses Louis Pasteur- looks for a causative agent for rabies, says too small, can not find it 1892 Dimitry Ivanosky- studies tobacco disease, can not find
More informationVirion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics
Hepadnaviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Hepatitis viruses A group of unrelated pathogens termed hepatitis viruses cause the vast majority
More informationSlides are the property of the author and AASLD. Permission is required from both AASLD and the author for reuse.
Inarigivir Demonstrates Potent Dose Dependent Anti-Viral Activity in HBV Treatment-Naïve Patients: Role of HBeAg Status and Baseline HBsAg in Anti-Viral Response MF Yuen, M. Elkhashab, CY Chen, YF Chen,
More informationHistory electron microscopes
Viruses History Through the 1800s, many scientists discovered that something smaller than bacteria could cause disease and they called it virion (Latin word- poison) In the 1930s, after the invention of
More informationRegulation of cell signaling cascades by influenza A virus
The Second International Symposium on Optimization and Systems Biology (OSB 08) Lijiang, China, October 31 November 3, 2008 Copyright 2008 ORSC & APORC, pp. 389 394 Regulation of cell signaling cascades
More informationPREventing EMerging Pathogenic Threats (PREEMPT) Proposers Day
PREventing EMerging Pathogenic Threats (PREEMPT) Proposers Day Dr. Jim Gimlett, Program Manager DARPA Biological Technologies Office (BTO) January 30, 2018 Arlington, VA PREEMPT Agenda Proposers Day Objectives
More informationLEC 2, Medical biology, Theory, prepared by Dr. AYAT ALI
General Characteristics, Structure and Taxonomy of Viruses Viruses A virus is non-cellular organisms made up of genetic material and protein that can invade living cells. They are considered both a living
More informationSize nm m m
1 Viral size and organization Size 20-250nm 0.000000002m-0.000000025m Virion structure Capsid Core Acellular obligate intracellular parasites Lack organelles, metabolic activities, and reproduction Replicated
More informationSevere Acute Respiratory Syndrome (SARS) Coronavirus
Severe Acute Respiratory Syndrome (SARS) Coronavirus Coronaviruses Coronaviruses are single stranded enveloped RNA viruses that have a helical geometry. Coronaviruses are the largest of RNA viruses with
More informationCIDRAP Leadership Forum Infectious Disease BRIEFING
Center for Infectious Disease Research and Policy University of Minnesota CIDRAP Leadership Forum Infectious Disease BRIEFING December 13 th, 2017 CLF BRIEFING HOT TOPICS 1. Influenza (surveillance, vaccine,
More informationbrought to you by and REFERENCES
brought to you by www.thebacteriophages.org and www.phage.org REFERENCES 1. Butcher, S. J., T. Dokland, P. M. Ojala, D. H. Bamford, and S. D. Fuller. 1997. Intermediates in the assembly pathway of the
More informationUnit 13.2: Viruses. Vocabulary capsid latency vaccine virion
Unit 13.2: Viruses Lesson Objectives Describe the structure of viruses. Outline the discovery and origins of viruses. Explain how viruses replicate. Explain how viruses cause human disease. Describe how
More informationChapter 25. 바이러스 (The Viruses)
Chapter 25 바이러스 (The Viruses) Generalized Structure of Viruses 2 2 Virus Classification Classification based on numerous characteristics Nucleic acid type Presence or absence of envelope Capsid symmetry
More informationAnti-infectious Immunity
Anti-infectious Immunity innate immunity barrier structures Secretory molecules Phagocytes NK cells Anatomical barriers 1. Skin and mucosa barrier 2.hemo-Spinal Fluid barrier 3. placental barrier Phagocytic
More informationDOWNLOAD OR READ : VIRAL BOUND PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : VIRAL BOUND PDF EBOOK EPUB MOBI Page 1 Page 2 viral bound viral bound pdf viral bound Viral load, also known as viral burden, viral titre or viral titer, is a numerical expression of
More informationInnate Immunity & Inflammation
Innate Immunity & Inflammation The innate immune system is an evolutionally conserved mechanism that provides an early and effective response against invading microbial pathogens. It relies on a limited
More informationChapter 6- An Introduction to Viruses*
Chapter 6- An Introduction to Viruses* *Lecture notes are to be used as a study guide only and do not represent the comprehensive information you will need to know for the exams. 6.1 Overview of Viruses
More informationUNRAVELING THE MYSTERY BEHIND HIV/AIDS
PRESS RELEASE 3 MAR 2010 UNRAVELING THE MYSTERY BEHIND HIV/AIDS New findings by Nobel Laureate shed light on the elusive AIDS virus and may lead to effective HIV vaccine development 1. Professor Francoise
More informationForward Looking Statements
Antiviral Therapies Forward Looking Statements This presentation contains forward-looking statements, including the timing of our drug development programs. Risks include delays in manufacturing created
More informationTHE IMPACT OF HLA CLASS I ON VIROLOGICAL OUTCOMES OF HBV
THE IMPACT OF HLA CLASS I ON VIROLOGICAL OUTCOMES OF HBV Philippa Matthews Consultant in Infectious Diseases & Microbiology SUPPRESSION CO-EVOLUTION ESCAPE Host factors associated with the clinical course
More informationJ. A. Sands, 21 October 2013 Lehigh University
J. A. Sands, 21 October 2013 Lehigh University Cryptococcus, Candidiasis, Aspergillosis Tuberculosis Cholera Plague Bact. Meningitis Salmonella Listeria Leptospirosis Staph. (MRSA) E. coli Clostridium
More informationRotavirus Genotyping and Enhanced Annotation in the Virus Pathogen Resource (ViPR) Yun Zhang J. Craig Venter Institute ASV 2016 June 19, 2016
Rotavirus Genotyping and Enhanced Annotation in the Virus Pathogen Resource (ViPR) Yun Zhang J. Craig Venter Institute ASV 2016 June 19, 2016 Loading Virus Pathogen Database and Analysis About Resource
More informationViruses. CLS 212: Medical Microbiology Miss Zeina Alkudmani
Viruses CLS 212: Medical Microbiology Miss Zeina Alkudmani History Through the 1800s, many scientists discovered that something smaller than bacteria could cause disease and they called it virion (Latin
More informationValidation of Relationship Between Free Chlorine Dose and Pathogen Inactivation in Drinking Water
Validation of Relationship Between Free Chlorine Dose and Pathogen Inactivation in Drinking Water Dr Arran Canning Seqwater Satiya Wati, Alex Keegan, Duncan Middleton, Duncan Shillito, Michael Bartkow
More informationGeneral Virology I. Dr Esam Ibraheem Azhar (BSc, MSc, Ph.D Molecular Medical Virology) Asst. Prof. Medical Laboratory Technology Department
General Virology I Dr Esam Ibraheem Azhar (BSc, MSc, Ph.D Molecular Medical Virology) Asst. Prof. Medical Laboratory Technology Department ١ General Virology I Lecture Outline Introduction istory Definition
More informationAntiviral Chemotherapy
12 Antiviral Chemotherapy Why antiviral drugs? Vaccines have provided considerable success in preventing viral diseases; However, they have modest or often no therapeutic effect for individuals who are
More informationMalik Sallam. Ola AL-juneidi. Ammar Ramadan. 0 P a g e
1 Malik Sallam Ola AL-juneidi Ammar Ramadan 0 P a g e Today's lecture will be about viral upper respiratory tract infections. Those include: common cold, sinusitis, otitis, etc. Infections in the upper
More informationHepatitis C Virus resistance screening and phenotypic NS3-PI-Resistance characterization. Arevir Meeting, 08./09.05.
Hepatitis C Virus resistance screening and phenotypic NS3-PI-Resistance characterization Arevir Meeting, 08./09.05.2014 Daniel Rupp HCV prevalence 130-170 million patients world wide Ca. 75% of infections
More informationOverview of the Immune System
Overview of the Immune System Immune System Innate (Nonspecific) Adaptive (Specific) Cellular Components Humoral Components Cell-Mediated Humoral (Ab) Antigens Definitions Immunogen Antigen (Ag) Hapten
More informationViral Genetics. BIT 220 Chapter 16
Viral Genetics BIT 220 Chapter 16 Details of the Virus Classified According to a. DNA or RNA b. Enveloped or Non-Enveloped c. Single-stranded or double-stranded Viruses contain only a few genes Reverse
More informationAntivirals. Lecture 20 Biology 3310/4310 Virology Spring 2017
Antivirals Lecture 20 Biology 3310/4310 Virology Spring 2017 You can t go back and you can t stand still. If the thunder don t get you, then the lightning will. JERRY GARCIA The Wheel (lyrics by Robert
More informationSina Bavari, Ph.D. US Army Medical Research Institute of Infectious Diseases (USAMRIID) Frederick, MD
Lassa Virus Therapeutics and Target Product Profile Sina Bavari, Ph.D. US Army Medical Research Institute of Infectious Diseases (USAMRIID) Frederick, MD sina.bavari.civ@mail.mil Objectives: 1) How to
More information23 ε Γηεκερίδα Ιογελώλ Ηπαηηηίδωλ Β θαη C «Ση. Χαηδεγηάλλες» 30 θαη 31 Ιαλοσαρίοσ 2016
23 ε Γηεκερίδα Ιογελώλ Ηπαηηηίδωλ Β θαη C «Ση. Χαηδεγηάλλες» 30 θαη 31 Ιαλοσαρίοσ 2016 Λεηηοσργηθή θαη Ιοιογηθή Ιαζε ηες Χρολίας Ηπαηίηηδας Β: Παρόλ θαη Μέιιολ Σηέθαλος Χαηδεγηάλλες Οκόηηκος Καζεγεηής
More informationSyllabus: Principles of Virology
Syllabus: Principles of Virology 1. Course Infromation: Title: Principles of Virology Number: F494 Credits: 3 Prerequisits: Biol 261 Location: To be determined 2. Instructor contact information: Karsten
More informationViral Determinants of Resistance to Treatment in Patients with Hepatitis C
CLINICAL MICROBIOLOGY REVIEWS, Jan. 2007, p. 23 38 Vol. 20, No. 1 0893-8512/07/$08.00 0 doi:10.1128/cmr.00010-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. Viral Determinants
More information